ÂÜÀòÂÒÂ×

Kyle Berkowitz currently serves as the Director of Business Analytics & Forecasting at UCB, overseeing a $1.5B US Immunology business unit. They provide market analysis, performance reports, and executive decision support. Previously, Kyle spent a decade as a management consultant focused on the pharmaceutical and medical device industries, leading client engagements and managing delivery teams. They hold an MBA in Corporate Finance and Strategy from Duke University, as well as both an MS and a BS in Mechanical Engineering from the Georgia Institute of Technology.